Showing 121-130 of 3101 results for "".
Psychiatric Comorbidity in Epilepsy: New Evidence from AES 2025
https://practicalneurology.com/programs/practical-neurology/psychiatric-comorbidity-in-epilepsy-new-evidence-from-aes-2025/39914/Ali Rafati, MD, MPH, Johns Hopkins Medicine, Baltimore, MD, and Churl-Su Kwon, MD, MPH, Columbia University Irving Medical Center, New York, NY, present new data from AES 2025 which reveal how depression and epilepsy are bidirectionally linked—and why neurologists must rethink screening and early inBotox for Chronic Migraine: Tips and Tricks
https://practicalneurology.com/diseases-diagnoses/headache-pain/botox-for-chronic-migraine-tips-and-tricks/30277/Ten Questions for Andrew M. Blumenfeld, MDNew Guidelines for the Assessment of Traumatic Brain Injury
https://practicalneurology.com/diseases-diagnoses/tbi/new-guidelines-for-the-assessment-of-traumatic-brain-injury/35727/Beth McQuiston, MD, RD, Medical Director, Abbott, Abbott Park, IL, and David Okonkwo, MD, PhD, Professor of Neurological Surgery, the University of Pittsburgh, Pittsburg, PA, describe some of the important updates to guidelines for the assessment of traumatic brain injury, including biomarker testinRadiologic Differential Diagnosis of Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/radiologic-differential-diagnosis-of-multiple-sclerosis/54601/This article provides an overview of the radiographic features that are shared and those that are distinct among multiple sclerosis, aquaporin-4 antibody–positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte protein antibody–associated disease.Young-Onset ALS: Diagnosis and Research
https://practicalneurology.com/diseases-diagnoses/neuromuscular/young-onset-als-diagnosis-and-research/30098/In this episode, Gwen Petersen discusses her long journey to receiving an ALS diagnosis at age 32, her contributions to a Cytokinetics book project, and the importance of clinical trial participation. We are also joined by Merit Cudkowicz, MD, MSc, Head of the Department of Neurology, Chief of NeuroA Coming of Age for Neuroimmunology
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/a-coming-of-age-for-neuroimmunology/30122/Increasingly complex diagnostics and highly effective disease-modifying therapy come with challenges in clinical decision making.Updates in Bruton Tyrosine Kinase Inhibition for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/updates-in-bruton-tyrosine-kinase-inhibition-for-multiple-sclerosis/31975/Ongoing clinical trials will elucidate potential advantages and safety of these novel medications for future treatment of multiple sclerosis.In-Focus: Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/in-focus-multiple-sclerosis/30371/Retooling Multiple Sclerosis CareTreating Early Relapsing Multiple Sclerosis: Induction & Escalation Approaches
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treating-early-relapsing-multiple-sclerosis-induction-escalation-approaches/31873/Evidence-based clinical trial results are needed to guide this difficult decision-making processExpert Perspective on Ocrelizumab and More
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/expert-perspective-on-ocrelizumab-and-more/30368/